20. November 2009 03:27
For the first time, scientists have successfully used a method called exome sequencing to quickly discover a previously unknown gene responsible for a mendelian disorder.
[More]
7. November 2009 00:05
Genetix Pharmaceuticals, a leader in gene therapy of somatic stem cells, announced today the company’s clinical program to treat Adrenoleukodystrophy (ALD). The company is developing a gene therapy product in collaboration with Professor Patrick Aubourg and Doctor Nathalie Cartier of the National Institute of Health and Medical Research (INSERM).
[More]
2. November 2009 23:46
Researchers at the University of Illinois at Chicago will use a $2 million federal grant to investigate why patients with sickle cell disease experience chronic pain -- and to develop drugs to treat it.
[More]
31. October 2009 00:49
Thousands of men are afflicted with an embarrassing and painful condition that triggers spontaneous, long-lasting erections. There are limited treatment options, but a solution could be on the way thanks to new research at The University of Texas Health Science Center at Houston.
[More]
29. October 2009 12:28
Physician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute of Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly.
[More]
cbc98788-e0e9-425f-9227-647969fdceb8|1|5.0
Posted in: Medical Science News | Medical Condition News
Tags: Blindness, Cancer, Cell, Gene Therapy, Hospital, Immunology, Macular Degeneration, Ophthalmology, Pathology, Pediatrics, Sickle Cell Disease, Stem Cell
29. October 2009 04:36
St. Jude Children's Research Hospital investigators were recently awarded a $23 million federal grant to launch a national study of the drug hydroxyurea to prevent first strokes in children and adolescents with sickle cell anemia (SCA).
[More]
17957f1f-a3e3-413b-8580-efca4e88cffd|0|.0
Posted in: Child Health News | Medical Condition News
Tags: Anemia, Blood Disorder, Brain, Cancer, Cell, Hematology, Hospital, Sickle Cell Anemia, Sickle Cell Disease, Stroke, Ultrasound
29. October 2009 02:54
Physician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute of Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly.
[More]
c7bd6622-47a8-4643-b884-e65950872e5e|0|.0
Posted in: Medical Condition News
Tags: Blindness, Cancer, Cell, Gene Therapy, Hospital, Immunology, Macular Degeneration, Ophthalmology, Pathology, Pediatrics, Sickle Cell Disease, Stem Cell
27. October 2009 06:36
For men coping with painful erections lasting for long periods of time, or priapism, new research published online in The FASEB Journal (http://www.fasebj.org) offers hope. That's because researchers from the United States and China show that the enzyme adenosine deaminase may prevent priapism from progressing to penile fibrosis, a condition associated with the build up of scar tissue and eventual impotence.
[More]
23. October 2009 08:12
An extract in red grape skin may be a new treatment for sickle cell disease, Medical College of Georgia researchers say.
[More]
22. October 2009 08:16
Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations.
[More]
90c778e5-530b-49e3-b01b-4ed4d0d8fd86|0|.0
Posted in: Device / Technology News | Medical Science News
Tags: Anemia, Autoimmune Disease, Cell, Chronic Lymphocytic Leukemia, DNA, Hypercholesterolemia, Leukemia, Lymphoma, Pathology, Sickle Cell Disease, Thalassemia
21. October 2009 00:31
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
[More]
8. October 2009 00:44
Aflac announced that it has raised more than $1.16 million for the Aflac Cancer Center through a matching grant campaign with Causes on Facebook, making it the largest sponsored campaign in the history of Causes. The effort also resulted in 851,215 new members joining the Aflac Cancer Center Cause, helping to generate awareness and financial support during Childhood Cancer Awareness Month.
[More]
7. October 2009 02:30
Cryo-Cell International, a global leader in stem cell innovation, is proud to be making progress in the fight against breast cancer through research and development using stem cells from menstrual blood.
[More]
ef9f21a1-2e6d-415e-a534-eb7a8a42dcad|0|.0
Posted in: Medical Science News | Women's Health News
Tags: Alzheimer's Disease, Breast Cancer, Cancer, Cell, Diabetes, Hodgkin's Disease, Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin's Lymphoma, Parkinson's Disease, Sickle Cell Disease, Spinal Cord Injury, Stem Cell, Stroke
1. October 2009 07:52
Sangamo BioSciences, Inc. announced today that research led by Donald B. Kohn, M.D., Professor of Microbiology, Immunology and Molecular Genetics (MIMG) and Pediatrics, the Director of the UCLA Human Gene Medicine Program and member of the Broad Stem Cell Research Center, and Philip Gregory, D. Phil., Sangamo's chief scientific officer and vice president, research, has been selected to receive a $486,000 Doris Duke Innovations in Clinical Research Award from the Doris Duke Charitable Foundation.
[More]
225b0160-7ecf-4a53-936d-ee8a2d2e848e|0|.0
Posted in: Medical Science News
Tags: Anemia, Cancer, Cell, Diabetic Neuropathy, DNA, Gene Expression, Genetics, HIV/AIDS, Immunology, Life Expectancy, Neuropathy, Parkinson's Disease, Pediatrics, Sickle Cell Anemia, Sickle Cell Disease, Stem Cell, Zinc
25. September 2009 07:00
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.
[More]
d38a92d3-3a9c-4275-9282-9adf4d23d002|0|.0
Posted in: Pharmaceutical News
Tags: Alzheimer's Disease, Anemia, Arthritis, Cancer, Cardiovascular Disease, Cell, Crohn's Disease, Diabetes, Embryonic Stem Cell, Gene Therapy, Hodgkin's Lymphoma, Incontinence, Infertility, Leukemia, Lupus, Lymphoma, Multiple Myeloma, Multiple Sclerosis, Non-Hodgkin's Lymphoma, Osteoporosis, Parkinson's Disease, Sickle Cell Disease, Stem Cell, Urinary Incontinence
Subscribe